Can MRI better spot early breast cancer spread?

NCT ID NCT00874458

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether MRI can more accurately measure the size of ductal carcinoma in situ (a very early form of breast cancer) compared to standard mammography. Forty women with the condition had MRI scans before surgery. Researchers then compared the MRI results with the actual tumor size found during surgery to see how well MRI predicts the extent of disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

magnetic resonance imaging (MRI)

What this could lead to

If successful, MRI could become a standard tool to more accurately assess how far ductal carcinoma in situ has spread before surgery.

What could go wrong

This is a small, completed study with only 40 participants, so results may not apply to all patients. MRI may not always match surgical findings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm ductal breast carcinoma in situ

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Antoine Lacassagne

    Nice, 06189, France